Principal Investigator
Agustin Pimentel
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20220773
Clinical Trial Summary
A Phase 1b/2 Placebo Controlled, Double Blinded Study on the
Efficacy and Safety of BXQ-350 in Combination with mFOLFOX7
and Bevacizumab in Newly Diagnosed Metastatic Colorectal
Carcinoma
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Colorectal Cancer
Contact Information
Phone Number
305-243-2647